Covered recipient · General Payments record
AMBER BREANNE WATSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$1,030.67
- Reported across 52 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $544.82 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Indivior Inc. | $167.64 | 10 |
| ABBVIE INC. | $120.95 | 4 |
| Neuronetics, Inc. | $59.16 | 1 |
| Braeburn Inc. | $51.19 | 3 |
| ITI, Inc. | $37.21 | 2 |
| Orexo US, Inc. | $36.07 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $28.85 | 1 |
| Alkermes, Inc. | $22.52 | 1 |
| Neurocrine BioSciences, Inc. | $21.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.90 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106758711 | CMS |
| ABBVIE INC. | $34.40 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106758714 | CMS |
| ABBVIE INC. | $32.54 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106758719 | CMS |
| ABBVIE INC. | $20.11 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106758723 | CMS |
| Alkermes, Inc. | $22.52 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120467409 | CMS |
| Boston Scientific Corporation | $28.85 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092653311 | CMS |
| Braeburn Inc. | $15.35 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125609268 | CMS |
| Braeburn Inc. | $21.93 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125609270 | CMS |
| Braeburn Inc. | $13.91 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125609272 | CMS |
| Indivior Inc. | $18.20 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144544401 | CMS |
| Indivior Inc. | $22.33 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144544403 | CMS |
| Indivior Inc. | $19.26 | 02/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144544405 | CMS |
| Indivior Inc. | $15.03 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144544407 | CMS |
| Indivior Inc. | $15.29 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144544409 | CMS |
| Indivior Inc. | $14.60 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144544411 | CMS |
| Indivior Inc. | $16.20 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144544413 | CMS |
| Indivior Inc. | $14.19 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144544415 | CMS |
| Indivior Inc. | $17.10 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144544417 | CMS |
| Indivior Inc. | $15.44 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144544419 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20.61 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143376692 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16.60 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143376696 | CMS |
| Neurocrine Biosciences, Inc. | $21.23 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150973591 | CMS |
| Neuronetics, Inc. | $59.16 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1073311874 | CMS |
| Orexo US, Inc. | $20.63 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136177858 | CMS |
| Orexo US, Inc. | $15.44 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136178382 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.